Krystal Biotech Inc (KRYS)
161.10
+0.87
(+0.54%)
USD |
NASDAQ |
May 03, 16:00
161.00
-0.10
(-0.06%)
After-Hours: 20:00
Krystal Biotech Total Assets (Quarterly): 818.36M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 818.36M |
| September 30, 2023 | 790.35M |
| June 30, 2023 | 684.03M |
| March 31, 2023 | 531.85M |
| December 31, 2022 | 558.45M |
| September 30, 2022 | 576.38M |
| June 30, 2022 | 601.32M |
| March 31, 2022 | 616.87M |
| December 31, 2021 | 626.30M |
| September 30, 2021 | 451.10M |
| June 30, 2021 | 443.56M |
| March 31, 2021 | 443.02M |
| December 31, 2020 | 310.84M |
| September 30, 2020 | 311.45M |
| Date | Value |
|---|---|
| June 30, 2020 | 318.14M |
| March 31, 2020 | 205.13M |
| December 31, 2019 | 209.02M |
| September 30, 2019 | 214.23M |
| June 30, 2019 | 205.16M |
| March 31, 2019 | 115.70M |
| December 31, 2018 | 116.12M |
| September 30, 2018 | 54.45M |
| June 30, 2018 | 46.03M |
| March 31, 2018 | 47.85M |
| December 31, 2017 | 50.11M |
| September 30, 2017 | 52.67M |
| June 30, 2017 | 3.977M |
| December 31, 2016 | 2.182M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
205.13M
Minimum
Mar 2020
818.36M
Maximum
Dec 2023
469.24M
Average
451.10M
Median
Sep 2021
Total Assets (Quarterly) Benchmarks
| Axsome Therapeutics Inc | 588.24M |
| Alnylam Pharmaceuticals Inc | 3.824B |
| Catalyst Pharmaceuticals Inc | 470.11M |
| Ionis Pharmaceuticals Inc | 2.990B |
| Madrigal Pharmaceuticals Inc | 640.55M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 39.71M |
| Shareholders Equity (Quarterly) | 778.64M |
| Current Ratio | 17.76 |